Capital Rx Audit: What Independent Pharmacies Should Expect

Capital Rx built its reputation on transparent-model pricing, itemizing drug costs against the National Average Drug Acquisition Cost (NADAC) instead of the spread-pricing arrangements common among traditional PBMs. In July 2026, the company's parent, Judi Health, renamed the PBM Judi Rx. Independent pharmacies working through an open audit are dealing with the same counterparty, the same claims history, and the same PBM audit exposure regardless of which name appears on the letterhead: recoupment demands, documentation disputes, and network standing.

Capital Rx Is Now Judi Rx

Judi Health announced the rebrand on July 15, 2026, folding Capital Rx's pharmacy benefit management business into Judi Rx alongside two new divisions, Judi Care and Judi Cloud. The pharmacy provider manual, the claims-processing systems, and the audit and appeal procedures pharmacies operate under did not change with the name. A pharmacy that receives correspondence on Judi Rx letterhead referencing a Capital Rx audit is dealing with the same counterparty and the same claims history.

How Claim-Level Reviews Unfold

Because the Clearinghouse Model discloses the drug cost itself, pricing disputes in a Capital Rx audit tend to center less on an opaque maximum allowable cost list and more on the underlying claim adjudication log: what the pharmacy dispensed, what it billed, and what documentation supports the fill. A typical desk audit requests the original prescription, the signature log, and wholesaler invoices proving the pharmacy held enough inventory to support the claims under review. Extrapolating a sample finding across the full lookback period remains a risk, the same exposure covered in What a PBM Audit Really Costs: Extrapolation and Recoupment Explained.

Where Disputes Usually Arise

Signature log gaps are the most common finding pharmacies dispute, particularly for maintenance medications delivered or mailed to a patient rather than signed for at the counter. Inventory shortfalls surface when wholesaler purchase records fail to reconcile against the volume of claims billed for a given NDC over the lookback period. Refill-too-soon and days-supply discrepancies round out the pattern. The same documentation gaps drive findings across transparent-model and traditional PBM audits alike, covered in more detail in Signature Log Findings in Pharmacy Audits and How to Rebut Them.

The Appeal and Grievance Process

Capital Rx's own pharmacist resources describe a two-stage process: a pharmacy disputing an audit finding files a first-level appeal, and only after that appeal is resolved can the pharmacy escalate through the formal Pharmacy Audit Grievance process. Pricing appeal decisions on individual claims are final and are not reopened for a second review, which makes the documentation submitted at the first appeal the pharmacy's only real opportunity to change the outcome. A finding that survives both stages can lead to a recoupment demand or, in a for-cause pattern, a network termination notice, the same audit appeal ladder that governs PBM contracts generally. Appeal deadlines and the specific procedural defenses available vary by PBM contract, as CVS Caremark Audit Appeals: Deadlines and Procedural Defenses lays out for a different PBM's process.

The audit exposure behind a transparent price carries the same recoupment risk as any other PBM contract, and the same short deadlines for a documented response.

Why Early Legal Counsel Is Critical

It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a Capital Rx or Judi Rx audit notice, a Pharmacy Audit Grievance denial, or any other PBM audit correspondence. Early legal intervention can protect the pharmacy's rights, ensure the documentation submitted at the first-level appeal is complete and consistent, avoid inadvertent admissions, preserve the pharmacy's audit appeal options, and let counsel communicate with the PBM's audit team on the pharmacy's behalf. Delaying representation until after a grievance decision becomes final can foreclose defenses that were available earlier in the process.

How Health Law Alliance Can Help

Health Law Alliance has overseen 2,000+ audits across traditional and transparent-model PBMs alike, and the firm's PBM audit defense practice represents pharmacies at every stage of a Capital Rx or Judi Rx audit, from the first documentation request through a final pricing appeal decision. If your pharmacy has received a Capital Rx or Judi Rx audit letter, contact us for a free, confidential consultation.